APA citiranje

Schoemaker, M. H., Kleemann, R., Morrison, M. C., Verheij, J., Salic, K., van Tol, E. A. F., . . . Wielinga, P. Y. (2017). A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice. PLoS One.

Citação norma Chicago

Schoemaker, Marieke H., Robert Kleemann, Martine C. Morrison, Joanne Verheij, Kanita Salic, Eric A. F. van Tol, Teake Kooistra, and Peter Y. Wielinga. "A Casein Hydrolysate Based Formulation Attenuates Obesity and Associated Non-alcoholic Fatty Liver Disease and Atherosclerosis in LDLr-/-.Leiden Mice." PLoS One 2017.

MLA citiranje

Schoemaker, Marieke H., et al. "A Casein Hydrolysate Based Formulation Attenuates Obesity and Associated Non-alcoholic Fatty Liver Disease and Atherosclerosis in LDLr-/-.Leiden Mice." PLoS One 2017.